Literature DB >> 8392791

Endometriosis and ovarian cancer.

P Vercellini1, F Parazzini, G Bolis, S Carinelli, M Dindelli, N Vendola, L Luchini, P G Crosignani.   

Abstract

In 556 patients undergoing surgery for ovarian cancers the frequency of endometriosis ranged from 3.6% to 5.6% in serous, mucinous, and miscellaneous neoplasms versus 26.3%, 21.1%, and 22.2%, respectively, in endometrioid, clear cell, and mixed subtypes; the differences were statistically significant (chi 2 heterogeneity 50.0, p < 0.001) and consistent in strata of age, parity, menopausal status, and disease stage.

Entities:  

Mesh：

Year:  1993        PMID： 8392791     DOI： 10.1016/0002-9378(93)90159-g

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  20 in total

1.  No evidence of endometriosis within serous and mucinous tumors of the ovary.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

Review 2.  Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.

Authors:  Yiying Wang; Maggie Mang; Yue Wang; Lijie Wang; Robert Klein; Beihua Kong; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Identification of common mechanisms between endometriosis and ovarian cancer.

Authors:  Qingsong Meng; Weixue Sun; John Jiang; Nicole M Fletcher; Michael P Diamond; Ghassan M Saed
Journal:  J Assist Reprod Genet       Date:  2011-05-26       Impact factor: 3.412

4.  Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.

Authors:  Wenbin Xiao; Amad Awadallah; Wei Xin
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

5.  An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Kozue Suzuki; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2009-08-05       Impact factor: 4.064

6.  Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Kosuke Miyai; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2009-10-24       Impact factor: 4.064

Review 7.  Precursors of endometrial and ovarian carcinoma.

Authors:  Robert J Kurman; Thomas G McConnell
Journal:  Virchows Arch       Date:  2009-10-27       Impact factor: 4.064

Review 8.  Endometriosis-associated Malignancy.

Authors:  N Krawczyk; M Banys-Paluchowski; D Schmidt; U Ulrich; T Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

9.  The status of telomerase enzyme activity in benign and malignant gynaecologic pathologies.

Authors:  Ilhami Gül; Ozgür Dündar; Serkan Bodur; Yusuf Tunca; Levent Tütüncü
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

10.  A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age.

Authors:  Hiroaki Kajiyama; Mika Mizuno; Kiyosumi Shibata; Tomokazu Umezu; Shiro Suzuki; Eiko Yamamoto; Hiroko Mitsui; Ryuichiro Sekiya; Kaoru Niimi; Michiyasu Kawai; Tetsuro Nagasaka; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2013-12-05       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.